Shabbir, A., Yumn, L., & Khan, E. (2024). Mavacamten’s therapeutic impact: cardiac-specific myosin inhibition in obstructive hypertrophic cardiomyopathy. Global Cardiology, 2(3). https://doi.org/10.4081/cardio.2024.48